Molecular imprinted magnetic nanoparticles for controlled delivery of mitomycin C
Source abstract
Abstract
Controlled drug delivery system is a technique which has considerable recent potential in the fields of pharmacy and medicine. Mitomycin C is commonly used drug in the treatment of superficial bladder and breast cancers. In the present study, mitomycin C-imprinted magnetic poly(hydroxyethyl methacrylate)-based nanoparticles (MIMNs) were prepared using surfactant free emulsion polymerization for controlled delivery of mitomycin C. The MIMNs were characterized by fourier transform infrared spectroscopy, scanning electron microscopy, atomic force microscopy, electron spin resonance, and elemental analysis. The average particle diameter of MIMNs was about 200 nm.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Analytical chemistry methods development · Mass Spectrometry Techniques and Applications · Luminescence and Fluorescent Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (53)
Show source-provided references
1. Allender CJ · Int J Pharm. · 2000 · 195 · 3910.1016/S0378-5173(99)00355-5 ↗
2. Alvarez-Lorenzo C · Biotechnol Ann Rev. · 2006 · 12 · 22510.1016/S1387-2656(06)12007-4 ↗
3. Arias JL · Molecules. · 2008 · 13 · 234010.3390/molecules13102340 ↗
4. Bereli N · J Chromatogr A. · 2008 · 1190 · 1810.1016/j.chroma.2008.02.110 ↗
5. Bereli N · Sep Purif Technol. · 2011 · 82 · 2810.1016/j.seppur.2011.08.011 ↗
6. Blanco MD · J Microencapsulation. · 2005 · 22 · 67110.1080/02652040500161990 ↗
7. Blanco MD · Polym Int. · 2008 · 57 · 121510.1002/pi.2457 ↗
8. Bryne ME · Adv Drug Deliv Rev. · 2002 · 54 · 14910.1016/S0169-409X(01)00246-0 ↗
9. Calarco A · J Cell Biochem. · 2010 · 110 · 90310.1002/jcb.22602 ↗
10. Cao Y · Ann Biomed Eng. · 2011 · 39 · 245610.1007/s10439-011-0333-2 ↗
11. Cheung RY · Biomaterials. · 2005 · 26 · 537510.1016/j.biomaterials.2005.01.050 ↗
12. Cirillo G · J Drug Traget. · 2009 · 17 · 7210.1080/10611860802455813 ↗
13. Denizli A · Biomaterials. · 1988 · 9 · 25710.1016/0142-9612(88)90094-4 ↗
14. Denizli A · Biomaterials. · 1988 · 9 · 36310.1016/0142-9612(88)90034-8 ↗
15. Duan L · J Control Release. · 2011 · 152 · 1810.1016/j.jconrel.2011.08.096 ↗
16. Ekberg B · Trends Biotechnol. · 1989 · 7 · 9210.1016/0167-7799(89)90006-1 ↗
17. Fournier E · Eur J Pharm Biopharm. · 2004 · 57 · 18910.1016/S0939-6411(03)00146-2 ↗
18. Hiratani H · J Control Release. · 2002 · 83 · 22310.1016/S0168-3659(02)00213-4 ↗
19. Hiratani H · Macromol Biosci. · 2005 · 5 · 72810.1002/mabi.200500065 ↗
20. Hu B · Colloids Surf B. · 2011 · 84 · 55010.1016/j.colsurfb.2011.02.016 ↗
21. Johnson RP · Adv Functl Mater. · 2012 · 22 · 105810.1002/adfm.201102756 ↗
22. Karakoç V · Int J Biol Macromol. · 2009 · 45 · 18810.1016/j.ijbiomac.2009.04.023 ↗
23. Kiremitçi M · 1986 · 1010
24. Kirsch N · Polymers. · 2000 · 41 · 558310.1016/S0032-3861(99)00782-X ↗
25. Kurita T · Int J Pharmaceutics. · 2004 · 275 · 27910.1016/j.ijpharm.2004.01.037 ↗
26. Li P · Colloids Surf B. · 2013 · 101 · 25110.1016/j.colsurfb.2012.07.009 ↗
27. Liu J · Spine J. · 2010 · 10 · 44110.1016/j.spinee.2010.02.017 ↗
28. Mosbach K · Trends Biochem Sci. · 1994 · 19 · 910.1016/0968-0004(94)90166-X ↗
29. Mosbach K · Nat Biotechnol. · 1996 · 14 · 16310.1038/nbt0296-163 ↗
30. 10.1002/(SICI)1099-1352(199812)11:1/6<98::AID-JMR399>3.0.CO;2-Y10.1002/(SICI)1099-1352(199812)11:1/6<98::AID-JMR399>3.0.CO;2-Y ↗
31. Öztürk N · Sep Purif Technol. · 2007 · 58 · 8310.1016/j.seppur.2007.07.037 ↗
32. Pişkin E · Proceedings of the 12th International Symposium on Controlled Release of Bioactive Materials, July 8–12 · 1985
33. Poma A · Trends Biotechnol. · 2010 · 28 · 62910.1016/j.tibtech.2010.08.006 ↗
34. Puoci F · Macromol Biosci. · 2004 · 4 · 2210.1002/mabi.200300035 ↗
35. 10.3390/1204080510.3390/12040805 ↗
36. Rauth AM · Cancer Res. · 1983 · 43 · 4154
37. Rochwell S · Cell Prolif. · 1994 · 27 · 15310.1111/j.1365-2184.1994.tb01413.x ↗
38. Sellergren B · Trends Anal Chem. · 1997 · 16 · 31010.1016/S0165-9936(97)00027-7 ↗
39. Singh B · Acta Biomaterialia. · 2008 · 4 · 124410.1016/j.actbio.2008.03.017 ↗
40. Soyez H · J Controlled Release. · 1997 · 47 · 7110.1016/S0168-3659(96)01617-3 ↗
41. Suedee R · J Control Release. · 2000 · 66 · 13510.1016/S0168-3659(99)00261-8 ↗
42. Suedee R · Drug Dev Ind Pharm. · 2002 · 28 · 54510.1081/DDC-120003450 ↗
43. Suisha F · Int J Pharmaceutics. · 1998 · 172 · 2710.1016/S0378-5173(98)00157-4 ↗
44. Türkmen D · Biotechnol Prog. · 2008 · 24 · 129710.1002/btpr.31 ↗
45. Whitcombe MJ · J Am Chem Soc. · 1995 · 117 · 710510.1021/ja00132a010 ↗
46. Wizeman W · Biomaterials. · 2001 · 22 · 148510.1016/S0142-9612(00)00303-3 ↗
47. Xiang SD · Nanomed Nanobiotechnol. · 2010 · 2 · 20510.1002/wnan.88 ↗
48. Yerriswamy B · Asian J Pharmaceutics. · 2010 · 4 · 20010.4103/0973-8398.72118 ↗
49. Yıldırmaz G · J Appl Polym Sci. · 2003 · 87 · 97610.1002/app.11397 ↗
50. Yıldırmaz G · React Functl Polym. · 2003 · 56 · 10310.1016/S1381-5148(03)00047-6 ↗
51. 10.1002/jmr.79310.1002/jmr.793 ↗
52. Zhang SJ · Polym Adv Technol. · 2011 · 22 · 28610.1002/pat.1766 ↗
53. Zimmermann C · Current Eye Res. · 1994 · 29 · 1